18-Year-Old Princeton Student Creates AI to Forecast Tumor Response to Cisplatin
Mythreya Dharani, an 18-year-old senior at Princeton High School, earned a spot among the top 40 finalists in the 2026 Regeneron Science Talent Search for an AI model that predicts how individual tumors will react to the chemotherapy drug cisplatin.
Mythreya Dharani, a senior at Princeton High School in New Jersey, was named a top-40 finalist in the 2026 Regeneron Science Talent Search after developing an artificial-intelligence model that forecasts individual tumor responses to cisplatin. The system merges machine-learning techniques with genomic information, aiming to guide doctors toward the most suitable treatment and avoid unnecessary toxicity. His physics-focused work also introduced a three-network architecture to process particle-collision data, preserving speed while correcting measurement errors.
Dharani balances his scientific pursuits with leadership as co-captain of the varsity debate team and mentorship through the UCLA Math Circle, where he teaches advanced mathematics to younger students. The Society for Science highlighted his achievement as a notable example of high-school-level contributions to personalized medicine. His recognition underscores the potential impact of early-stage innovators on future cancer therapies.
Why it matters
A high-school AI breakthrough could accelerate personalized cancer treatment and inspire young scientists.
In this story
